Skip to main content
. Author manuscript; available in PMC: 2019 Nov 13.
Published in final edited form as: Curr Osteoporos Rep. 2018 Aug;16(4):443–457. doi: 10.1007/s11914-018-0453-9

Table 2.

Oncomine (https://www.oncomine.org) gene analysis comparing the expression of fatty acid desaturases (FADS1 and FADS2) in patient samples collected from metastatic or primary sites across all cancers. Leukemia and multiple myeloma samples were compared to normal bone marrow. Data were ordered by “overexpression,” and the threshold was adjusted to P value < 1E4; fold change, 2; and gene rank, top 10%

Gene Fold change P value Dataset Analysis
FADS1 1.335 5.84E–7 Yu prostate Metastasis vs. primary
1.953 3.31E–5 Grasso prostate Metastasis vs. primary
1.353 0.002 Lapointe prostate Metastasis vs. primary
1.343 0.003 Bittner colon Metastasis vs. primary
1.124 0.006 Chen gastric Metastasis vs. primary
1.164 0.008 Bittner ovarian Metastasis vs. primary
1.307 0.010 Linn sarcoma Metastasis vs. primary
1.201 0.024 Graudens colon Metastasis vs. primary
1.447 0.025 Holzbeierlein prostate Metastasis vs. primary
2.593 0.034 Varambally prostate Metastasis vs. primary
1.807 0.037 Bittner lung Metastasis vs. primary
1.570 0.040 Segal sarcoma Metastasis vs. primary
1.508 0.042 Adib ovarian Metastasis vs. primary
2.022 0.064 Segal sarcoma 2 Metastasis vs. primary
1.119 0.068 Jones renal Metastasis vs. primary
3.378 0.082 Ramaswamy multi-cancer 2 Metastasis vs. primary
2.831 0.092 Ramaswamy multi-cancer Metastasis vs. primary
2.066 2.11E–57 Haferlach leukemia T cell ALL vs. normal
1.459 4.32E–36 Haferlach leukemia B cell childhood ALL vs. normal
1.427 8.31E–34 Haferlach leukemia AML vs. normal
1.444 1.36E–28 Haferlach leukemia B cell ALL vs. normal
1.170 3.05E–4 Haferlach leukemia CML vs. normal
FADS2 1.673 3.24E–6 Linn sarcoma Metastasis vs. primary
1.377 1.12E–5 Chandran prostate Metastasis vs. primary
1.357 0.011 Jones renal Metastasis vs. primary
1.399 0.016 Bittner colon Metastasis vs. primary
2.604 0.037 Varambally prostate Metastasis vs. primary
1.409 0.050 Lapointe prostate Metastasis vs. primary
1.204 0.050 Bittner ovarian Metastasis vs. primary
2.151 0.081 Liao liver Metastasis vs. primary
1.363 0.098 Holzbeierlein prostate Metastasis vs. primary
1.490 1.22E–12 Haferlach leukemia T cell ALL vs. normal
1.118 0.007 Haferlach leukemia AML vs. normal
1.097 0.058 Haferlach leukemia CML vs. normal
4.258 1.84E–5 Andersson leukemia T cell ALL vs. normal
1.746 0.010 Andersson leukemia AML vs. normal
1.503 0.027 Andersson leukemia B cell ALL vs. normal
1.425 0.002 Maia leukemia B cell ALL vs. normal
2.522 0.004 Zhan myeloma 3 Smoldering myeloma vs. normal